论文部分内容阅读
目的:观察复方苦参注射液对79例介入治疗的原发性肝癌患者免疫功能及生存质量影响。方法:采用复方苦参注射液对79例介入治疗的原发性肝癌患者进行研究,比较患者治疗前、后自身免疫能力与生活质量的改变。结果:两组患者CD4、CD4/CD8和NK细胞检测治疗后较治疗前有较好改善,组内比较差异有统计学意义(P<0.05)。治疗后组间比较,治疗组较对照组有明显好转,组间比较差异有统计学意义(P<0.05)。两组患者治疗后生活质量评分均有不同程度的改善。治疗后比较,治疗组较对照组有明显好转,组间比较差异有统计学意义(P<0.05)。结论:复方苦参注射液对介入治疗的原发性肝癌患者免疫功能和生活质量有很好的改善作用。
Objective: To observe the effects of Compound Kushen Injection on immune function and quality of life in 79 patients with primary liver cancer undergoing interventional therapy. Methods: Compound Kushen injection was used to study 79 patients with primary liver cancer who underwent interventional therapy. The changes of autoimmune ability and quality of life before and after treatment were compared. Results: After treatment, CD4, CD4 / CD8 and NK cells in both groups were better than before treatment, the difference was statistically significant (P <0.05). After treatment, compared with the control group, the treatment group improved significantly, the difference between the two groups was statistically significant (P <0.05). Quality of life scores after treatment in both groups were improved to varying degrees. After treatment, the treatment group than the control group has improved significantly, the difference between the two groups was statistically significant (P <0.05). Conclusion: Compound Kushen injection can improve the immune function and quality of life of patients with primary liver cancer undergoing interventional therapy.